z-logo
open-access-imgOpen Access
Olanzapine Induced Deep Venous Thrombosis
Author(s) -
Sinan Genç,
Cuma Yıldırım,
Pınar Yarbil,
Hasan Kılıç,
Behçet Al
Publication year - 2011
Publication title -
journal of academic emergency medicine case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.112
0
eISSN - 1309-534X
pISSN - 2146-2925
DOI - 10.5505/jaemcr.2011.03274
Subject(s) - medicine , olanzapine , venous thrombosis , thrombosis , gynecology , psychiatry , schizophrenia (object oriented programming)
Cause of a lower risk of extrapyramidal side effects atypical antipsychotic drugs are primarily being used more frequently in schizophrenia and mania. Many metabolic side effects particularly such as obesity and dyslipidemia may occur in the use of atypical antipsychotic drugs. Numbers of studies that show a relationship between atypical antipsychotic use and the development of venous thromboembolism have been increasing. We discovered deep venous thrombosis in 33yearold male patient, who had been using olanzapine due to bipolar disorder, admitted to our emergency service with leg pain and swelling. In this case report we discussed that in a patient without risk factors for developing venous thromboembolism, the use of olanzapine may lead to deep venous thrombosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom